focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

Fri, 28th Oct 2022 21:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Tullow Oil PLC - London-based oil and gas exploration company - and Capricorn Energy PLC - Edinburgh-based oil and gas exploration and development company - Confirm that they will no longer proceed with a combination. The Takeover Panel has consented to the withdrawal of Tullow's associated offer. At end of September, Tullow set out plans to terminate its co-operation deal with Capricorn Energy PLC, after Capricorn proposed a merger with NewMed Energy Ltd. Capricorn also withdrew its recommendation for the previously agreed combination with Tullow.

----------

Inspecs Group PLC - Bath, England-based eyewear company - Chief Executive Officer Robin Christian Bjorn Totterman buys 378,376 shares at 52.47 pence each, totalling around GBP198,534.

----------

Kropz PLC - African phosphate developer - Enters into a new bridge loan facility of ZAR126 million, or GBP6.0 million, with its major shareholder, the ARC Fund, to meet immediate cash requirements due to delays in the ramp-up of operations at Kropz Elandsfontein Pty Ltd.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Allots and issues a total of 4.8 million new ordinary shares of 5 pence each in Diurnal. This follows the court sanctioning the scheme in relation to the recommended cash offer by Neurocrine Biosciences Inc.

----------

Upland Resources Ltd - London-based oil and gas company - Pretax loss in the year which ended June 30 narrows to GBP494,295 versus GBP789,892 a year ago. Administrative expenses drop to GBP354,828 from GBP570,676. Registers an intangible asset impairment cost of GBP219,216 in the prior period. Records no revenue in the period, unchanged from a year before.

----------

Umuthi Healthcare Solutions PLC - London-based healthcare firm - Loss from operating activities in the six months to August 31 narrows to GBP6,329 from GBP82,500, year-on-year. Administrative expenses fall to GBP6,329 from GBP82,500. Records no revenue, unchanged from a year before.

----------

ADM Energy PLC - London-based natural resource investor - Raises GBP500,000 net through the issue of 41.7 million new ordinary shares to Tennessee Black Gold at a subscription price of 1.2 pence per share. The shares will represent 14% of its enlarged issued share capital. Says its subscriber has also agreed to provide the company with a loan facility of USD250,000, to be advanced in five monthly instalments of USD50,000 each.

----------

BlueRock Diamonds PLC - Reading-based diamond producer focused on South Africa - In the third quarter of 2022, produces 195,848 tonnes from its Kareevlei diamond mine in South Africa, up 23% versus 159,867t a year before. Sells 5,475 carats, down 21% from 6,887 carats quarter-on-quarter. "In order to adhere to the mining plan there was a significant increase in activity related to stripping, waste mined and movement of stockpiles," CEO Victor Dingle says. Revises its guidance for 2022 and 2023 to reflect the outcome of a high-level review undertaken of the production and mining plan and continued uncertainty over production and grade. Expects to 600,000t to 700,000t processed, down from 620,000t to 670,000t.

----------

Golden Prospect Precious Metals Ltd - investment fund - Pretax loss widens in the six months to June 30 to GBP9.4 million from GBP9.2 million a year ago. Fair value through loss widens to GBP8.9 million from GBP8.8 million. Records no income, unchanged from a year before.

----------

Bidstack Group PLC - London-based in-game advertising platform - Notes recent press commentary regarding a private communication by the company "with certain investors" concerning an email received from Azerion. Says contrary to the press commentary, there is no litigation with Azerion, and the contract with Azerion continues to operate as expected.

----------

SulNOx Group PLC - London-based supplier of fuel conditioners - Pretax loss in the six months to September 30 widens to GBP964,702 versus GBP724,121 a year before, as administrative expenses jump to GBP975,069 from GBP723,718. Revenue triples to GBP74,805 from GBP24,486. Says it is starting to see "significant traction" in the sales of its SulNOxEco Fuel Conditioner product. Says revenue pipeline is strong and diversified by geography and industry.

----------

MAC Alpha Ltd - acquisition vehicle listed on LSE - Records a pretax loss of GBP266,043 in the period from incorporation on October 11 to June 30. Registers administrative expenses of GBP266,043.

----------

Marwyn Acquisition Co III Ltd - acquisition vehicle - Pretax loss in the year to June 30 widens to GBP1.1 million from GBP636,141, year-on-year. Records a GBP254,000 movement in the fair value of warrants. Administrative expenses rise to GBP892,233 versus GBP636,141. Records no revenue, unchanged from a year before. Remains confident in delivering its strategy and creating significant value for its shareholders.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 May 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

Read more
15 Apr 2020 14:32

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

Read more
1 Apr 2020 14:47

Diurnal Gets European Marketing Authorisation For Chronocort

Diurnal Gets European Marketing Authorisation For Chronocort

Read more
6 Mar 2020 17:12

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

Read more
6 Mar 2020 12:40

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Read more
6 Mar 2020 10:07

Diurnal raises at least ?7m through conditional placing

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced a conditional placing with institutional investors on Friday, to raise at least ?7m before expenses, at a price of 32p per new share.

Read more
5 Mar 2020 17:21

Diurnal Group Names Director Sam Williams Interim Chair

Diurnal Group Names Director Sam Williams Interim Chair

Read more
13 Feb 2020 13:07

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Read more
13 Feb 2020 09:47

Diurnal clears FDA hurdle for 'Alkindi Sprinkle'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Thursday that its new drug application (NDA) for 'Alkindi', or hydrocortisone granules in capsules for opening and to be known in the US as 'Alkindi Sprinkle', has been accepted for review by the US Food and Drug Administration (FDA).

Read more
11 Feb 2020 13:45

Diurnal narrows loss as it progresses drugs to market

(Sharecast News) - Speciality pharmaceutical company Diurnal Group narrowed its first-half loss by 53% to ?4.6m, it announced on Tuesday, which it said reflected improved revenues and a reduction in clinical development expenses for the period.

Read more
11 Feb 2020 09:20

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Read more
4 Feb 2020 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jan 2020 11:17

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Read more
16 Dec 2019 13:20

Diurnal Submits Market Authorisation Application For Chronocort

Diurnal Submits Market Authorisation Application For Chronocort

Read more
2 Dec 2019 14:40

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.